Inspire Medical Systems, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Inspire Medical Systems, Inc. (INSP) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 134.82 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-02-13
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 56.62K shares, a 128.92% increase year-over-year.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 24.21K shares, a 69.05% decline year-over-year.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-06-30 was 25.73K shares, a 6.59% decline year-over-year.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-03-31 was 28.26K shares, a 80.07% increase year-over-year.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 134.82K shares, a 7.78% decline from fiscal 2024.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 146.18K shares, a 144.46% increase from fiscal 2023.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 59.80K shares, a 13.39% decline from fiscal 2022.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 69.05K shares, a 40.36% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2025-12-31 | 56.62K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | 80.83K shares derived: sum of 2 quarters · filed 2026-02-13 | 106.55K shares derived: sum of 3 quarters · filed 2026-02-13 | 134.82K shares 10-K · filed 2026-02-13 |
| 2025-09-30 | 24.21K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | 49.94K shares derived: sum of 2 quarters · filed 2025-11-03 | 78.20K shares 10-Q · filed 2025-11-03 | 102.93K shares derived: sum of 4 quarters · filed 2026-02-13 |
| 2025-06-30 | 25.73K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | 53.99K shares 10-Q · filed 2025-08-04 | 78.72K shares derived: sum of 3 quarters · filed 2026-02-13 | 156.94K shares derived: sum of 4 quarters · filed 2026-02-13 |
| 2025-03-31 | 28.26K shares 10-Q · filed 2025-05-05 | 52.99K shares derived: sum of 2 quarters · filed 2026-02-13 | 131.21K shares derived: sum of 3 quarters · filed 2026-02-13 | 158.75K shares derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-12-31 | 24.73K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | 102.94K shares derived: sum of 2 quarters · filed 2026-02-13 | 130.49K shares derived: sum of 3 quarters · filed 2026-02-13 | 146.18K shares 10-K · filed 2026-02-13 |
| 2024-09-30 | 78.21K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | 105.76K shares derived: sum of 2 quarters · filed 2024-11-04 | 121.45K shares 10-Q · filed 2024-11-04 | 140.85K shares derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | 27.55K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | 43.24K shares 10-Q · filed 2024-08-06 | 62.64K shares derived: sum of 3 quarters · filed 2026-02-13 | 76.13K shares derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | 15.70K shares 10-Q · filed 2024-05-07 | 35.09K shares derived: sum of 2 quarters · filed 2026-02-13 | 48.58K shares derived: sum of 3 quarters · filed 2026-02-13 | 60.80K shares derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | 19.39K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | 32.88K shares derived: sum of 2 quarters · filed 2026-02-13 | 45.10K shares derived: sum of 3 quarters · filed 2026-02-13 | 59.80K shares 10-K · filed 2026-02-13 |
| 2023-09-30 | 13.49K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | 25.71K shares derived: sum of 2 quarters · filed 2023-11-07 | 40.40K shares 10-Q · filed 2023-11-07 | 53.71K shares derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-06-30 | 12.22K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | 26.91K shares 10-Q · filed 2023-08-01 | 40.22K shares derived: sum of 3 quarters · filed 2025-02-10 | 50.50K shares derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-03-31 | 14.70K shares 10-Q · filed 2023-05-02 | 28.00K shares derived: sum of 2 quarters · filed 2025-02-10 | 38.28K shares derived: sum of 3 quarters · filed 2025-02-10 | 70.35K shares derived: sum of 4 quarters · filed 2025-02-10 |
| 2022-12-31 | 13.31K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | 23.58K shares derived: sum of 2 quarters · filed 2025-02-10 | 55.66K shares derived: sum of 3 quarters · filed 2025-02-10 | 69.05K shares 10-K · filed 2025-02-10 |
| 2022-09-30 | 10.27K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | 42.35K shares derived: sum of 2 quarters · filed 2022-11-01 | 55.74K shares 10-Q · filed 2022-11-01 | 77.72K shares derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-06-30 | 32.08K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | 45.47K shares 10-Q · filed 2022-08-02 | 67.45K shares derived: sum of 3 quarters · filed 2024-02-09 | 87.03K shares derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-03-31 | 13.39K shares 10-Q · filed 2022-05-03 | 35.37K shares derived: sum of 2 quarters · filed 2024-02-09 | 54.95K shares derived: sum of 3 quarters · filed 2024-02-09 | 86.59K shares derived: sum of 4 quarters · filed 2024-02-09 |
| 2021-12-31 | 21.98K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | 41.56K shares derived: sum of 2 quarters · filed 2024-02-09 | 73.20K shares derived: sum of 3 quarters · filed 2024-02-09 | 115.77K shares 10-K · filed 2024-02-09 |
| 2021-09-30 | 19.58K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | 51.22K shares derived: sum of 2 quarters · filed 2021-11-02 | 93.79K shares 10-Q · filed 2021-11-02 | 109.83K shares derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-06-30 | 31.64K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | 74.21K shares 10-Q · filed 2021-08-03 | 90.24K shares derived: sum of 3 quarters · filed 2023-02-10 | 98.05K shares derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-03-31 | 42.57K shares 10-Q · filed 2021-05-04 | 58.60K shares derived: sum of 2 quarters · filed 2023-02-10 | 66.41K shares derived: sum of 3 quarters · filed 2023-02-10 | 77.49K shares derived: sum of 4 quarters · filed 2023-02-10 |
| 2020-12-31 | 16.04K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | 23.84K shares derived: sum of 2 quarters · filed 2023-02-10 | 34.92K shares derived: sum of 3 quarters · filed 2023-02-10 | 66.12K shares 10-K · filed 2023-02-10 |
| 2020-09-30 | 7.81K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | 18.88K shares derived: sum of 2 quarters · filed 2020-11-02 | 50.09K shares 10-Q · filed 2020-11-02 | 56.34K shares derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | 11.07K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | 42.28K shares 10-Q · filed 2020-08-04 | 48.53K shares derived: sum of 3 quarters · filed 2022-02-15 | 73.04K shares derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | 31.21K shares 10-Q · filed 2020-05-05 | 37.46K shares derived: sum of 2 quarters · filed 2022-02-15 | 61.97K shares derived: sum of 3 quarters · filed 2022-02-15 | 73.73K shares derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | 6.25K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | 30.76K shares derived: sum of 2 quarters · filed 2022-02-15 | 42.52K shares derived: sum of 3 quarters · filed 2022-02-15 | 45.83K shares 10-K · filed 2022-02-15 |
| 2019-09-30 | 24.51K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | 36.27K shares derived: sum of 2 quarters · filed 2019-11-05 | 39.58K shares 10-Q · filed 2019-11-05 | 48.11K shares derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | 11.77K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | 15.07K shares 10-Q · filed 2019-08-06 | 23.60K shares derived: sum of 3 quarters · filed 2021-02-24 | 30.09K shares derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | 3.30K shares 10-Q · filed 2019-05-07 | 11.83K shares derived: sum of 2 quarters · filed 2021-02-24 | 18.33K shares derived: sum of 3 quarters · filed 2021-02-24 | |
| 2018-12-31 | 8.53K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | 15.02K shares derived: sum of 2 quarters · filed 2021-02-24 | 39.96K shares 10-K · filed 2021-02-24 | |
| 2018-09-30 | 6.49K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | 31.43K shares 10-Q · filed 2018-11-06 | ||
| 2018-06-30 | 24.93K shares 10-Q · filed 2018-08-07 | |||
| 2017-12-31 | 20.54K shares 10-K · filed 2020-02-25 | |||
| 2016-12-31 | 54.85K shares 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |